ADHD drugs
The FDA said is considering issuing warnings about possible safety risks associated with two commonly prescribed ADHD drugs. An FDA advisory panel meets today to evaluate evidence linking drugs used to treat attention deficit hyperactivity disorder to increased risk of death and other serious side effects. The controversy over ADHD medications has grown over the last few years, as new evidence has emerged suggesting they may increase health risks. Article